02.10.2015 Views

organisation - the Instituto Gulbenkian de Ciência

organisation - the Instituto Gulbenkian de Ciência

organisation - the Instituto Gulbenkian de Ciência

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

LUPUS<br />

AND AUTOREACTIVE<br />

IMMUNE REPERTOIRES<br />

Constantin Fesel Research Fellow<br />

PhD in Immunology, Université Paris VI, 1998<br />

Post-doctoral Fellow, Weizmann Institute of Science, Rehovot<br />

Principal Investigator at <strong>the</strong> IGC since 2001<br />

While <strong>the</strong> <strong>de</strong>tection of molecular mechanisms as well as of genetic disease risk<br />

factors rapidly evolves, <strong>the</strong> systemic diversification of specificity repertoires is<br />

still badly un<strong>de</strong>rstood. In this situation, it is increasingly relevant to mo<strong>de</strong>l <strong>the</strong><br />

pathogenetic process that leads to autoimmune diseases as a whole, since <strong>the</strong>y<br />

are known to <strong>de</strong>pend on complex interactions of molecular and cellular mechanisms.<br />

Systemic Lupus Ery<strong>the</strong>matosis (SLE) is a human autoimmune disor<strong>de</strong>r<br />

where altered physiologies and self-reactive repertoires of both B- and T-cells<br />

are intimately connected. Our approach is to mo<strong>de</strong>l, in a stepwise fashion, <strong>the</strong><br />

ways in which genetic factors and molecular mechanisms are interconnected.<br />

Since we found particular relations between antibody reactivity and regulatory<br />

T-cells in unaffected relatives of SLE patients who often share SLE-associated<br />

autoantibodies, our hypo<strong>the</strong>sis is that <strong>the</strong>se autoantibody-positive relatives<br />

bear a particular capacity to regulate autoimmune reactions.<br />

GROUP MEMBERS<br />

Nuno Costa (Research Technician)<br />

Sandra Iris Godinho (Masters stu<strong>de</strong>nt)<br />

COLLABORATORS<br />

Maria Berta Silva Martins (<strong>Instituto</strong> <strong>de</strong> Ciências Biomédicas Abel Salazar,<br />

Porto, Portugal)<br />

Carlos Vasconcelos (Hospital Geral <strong>de</strong> Santo Antonio, Porto, Portugal)<br />

Margarida Lima (Hospital Geral <strong>de</strong> Santo Antonio, Porto, Portugal)<br />

Cristina João (Centro <strong>de</strong> Investigação <strong>de</strong> Patologia Molecular, Lisboa,<br />

Portugal)<br />

Carlos Ferreira (Hospital <strong>de</strong> Santa Maria, Lisboa, Portugal)<br />

Maria Francisca Fontes (Hospital Curry Cabral, Lisboa, Portugal)<br />

José Alves (Hospital Fernando Fonseca, Amadora-Sintra, Portugal)<br />

FUNDING<br />

Fundação para a Ciência e Tecnologia (FCT), Portugal<br />

LUPUS AND ITS COMPENSATION IN UNAFFECTED RELATIVES<br />

BY T-CELL REGULATION<br />

SLE is an autoimmune disease characterised by autoantibodies that accumulate<br />

over years before clinical manifestation. Unaffected relatives of SLE patients<br />

frequently share SLE-type autoantibodies, most without ever acquiring clinical<br />

disease, which suggests a capacity to compensate pathogenic effects associated<br />

with <strong>the</strong>m. A <strong>the</strong>rapy that is able to restore such compensation appears<br />

highly <strong>de</strong>sirable. Conversely to reported negative correlations of regulatory T-<br />

cells with circulating IgG autoantibodies in patients, we found <strong>the</strong>m positively<br />

correlated in unaffected relatives. Fur<strong>the</strong>rmore, autoantibody profiles were influenced<br />

by genetic polymorphisms affecting effects mediated by IL2, <strong>the</strong> cytokine<br />

with <strong>the</strong> strongest impact on Treg function in characteristic ways. We<br />

hypo<strong>the</strong>sise that an IL2-<strong>de</strong>pen<strong>de</strong>nt regulatory feedback mechanism, abrogated<br />

in manifest SLE, can control <strong>the</strong> pathogenicity of SLE-type antibody production.<br />

We are now characterising this mechanism. Data analysis is in progress<br />

Scheme of SLE pathogenesis according to current knowledge, with <strong>the</strong> role of<br />

regulatory T-cells indicated.<br />

Cytogramme with subsets of conventional and regulatory T-cells.<br />

IGC ANNUAL REPORT ‘11<br />

RESEARCH FELLOWS<br />

74

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!